BIO financials
Bio-Rad (BIO) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
BIO income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $2.58B | $1.34B | $270.50M | $759.90M | 27.87 |
| 2024 | $2.57B | $1.38B | $269.00M | -$1.84B | -65.36 |
| 2023 | $2.67B | $1.43B | $337.80M | -$637.32M | -21.82 |
| 2022 | $2.80B | $1.57B | $482.62M | -$3.63B | -121.79 |
| 2021 | $2.92B | $1.64B | $500.34M | $4.25B | 140.83 |
| 2020 | $2.55B | $1.44B | $421.33M | $3.81B | 126.20 |
- BIO revenue was $2.58B in fiscal 2025, net income $759.90M.
Updated 2026-11-02 23:14 UTC